Clearone
CLRO · NASDAQ
$1.89+$0.17 (+9.88%)TodayMarket closed ·
Prev close $1.72
Who owns CLRO
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 71.6% of CLRO’s shares.
- First Finance Ltd61.2%
- Bagley (Edward Dallin)5.2%
- Shay Capital LLC1.7%
- T3 Companies, LLC1.1%
- Next 6 largest institutions2.3%
- All other shareholders28.4%
| Holder | Shares | % of shares |
|---|---|---|
| First Finance Ltd | 1.64M | 61.24% |
| Bagley (Edward Dallin) | 140.67K | 5.25% |
| Shay Capital LLC | 45.49K | 1.70% |
| T3 Companies, LLC | 30.00K | 1.12% |
| Bagley (Carolyn C) | 23.68K | 0.88% |
| Albion Financial Group | 14.46K | 0.54% |
| Geode Capital Management, L.L.C. | 10.83K | 0.40% |
| Vanguard Capital Management, LLC | 5.26K | 0.20% |
| Dimensional Fund Advisors, L.P. | 3.92K | 0.15% |
| Vanguard Fiduciary Trust Co | 2.40K | 0.09% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Vanguard Extended Market Index Fund | 17.08K | 0.64% |
| Fidelity Extended Market Index Fund | 5.85K | 0.22% |
| EA Bridgeway Omni Small-Cap Value ETF | 1.88K | 0.07% |
| DFA U.S. Vector Equity Fund | 1.85K | 0.07% |
| DFA U.S. Core Equity 2 Portfolio | 1.72K | 0.06% |
Insider trades
Form 4 filings by officers, directors and large holders
Insiders made no open-market buys or sales of CLRO in the last 6 months.
| Insider | Type | Shares | Value |
|---|---|---|---|
| First Finance Ltd. | Other | 437.50K | — |
Short interest
Settled Sep 30, 2026
- Shares short
- 387.28K
- Days to cover
- 1.00
- % of shares outstanding
- 14.45%
- Average daily volume
- 2.71M
- Change since last report
- +1407.6%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.